Fellowship · Washington, DC
Sponsored by George Washington University School of Medicine
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
The Lancet. Neurology · 2023 · 231 citations · Henry Kaminski
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology · 2023 · 218 citations · Henry Kaminski
Myasthenia gravis: the future is here.
The Journal of clinical investigation · 2024 · 93 citations · Henry Kaminski
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
Proceedings of the National Academy of Sciences of the United States of America · 2022 · 111 citations · Henry Kaminski
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Therapeutic advances in neurological disorders · 2024 · 35 citations · Henry Kaminski
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders.
The Lancet. Neurology · 2022 · 86 citations ·
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force.
Muscle & nerve · 2025 · 16 citations · Henry Kaminski
Deep brain stimulation targets in drug-resistant epilepsy: Systematic review and meta-analysis of effectiveness and predictors of response.
Seizure · 2024 · 15 citations · Mohammad Abu-Rub